Viewing Study NCT00453102

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:46 AM
Ignite Modification Date: 2026-05-19 @ 12:59 PM
Study NCT ID: NCT00453102
Status: COMPLETED
Last Update Posted: 2016-01-01
First Post: 2007-03-27
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Previously Untreated Marginal Zone Lymphoma
Sponsor: University of Miami
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Marginal Zone Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Marginal Zone Lymphoma View
None Non-gastric extranodal Marginal Zone Lymphoma View
None Splenic Marginal Zone Lymphoma View
None Nodal Marginal Zone Lymphoma View
None Gastric Marginal Zone Lymphoma View
None MZL View
None Non-gastric extranodal MZL View
None Splenic MZL View
None Nodal MZL View
None Gastric MZL View